Educational overview · Approx. 8 min read · illustrative, not advice
Michigan statute puts a consent step in front of telehealth treatment, requires a state controlled substance license, and limits who may co-own a professional entity. Detroit adds a city income tax and employer withholding. This page is general commentary, not legal advice.
Where the compounded market actually went, and why it matters to a Detroit build
A metabolic program's sourcing model is a strategic decision, not a purchasing detail. IQVIA reported in October 2025 that compounded semaglutide and tirzepatide prescribing did not abate after FDA delisting, that more than 80 percent of compounded prescriptions include supplemental ingredients such as B vitamins or levocarnitine, that anti-obesity patients were approximately 83 percent of the compounded market during the shortage period, and that roughly 2 percent of compounded patients switched to branded products monthly.
Read that as a description of a market in motion under regulatory pressure, not as a recommendation. FDA has stated that a compounded product with the same active ingredient is not the drug FDA reviewed and approved and that it does not evaluate specific compounded products for safety, effectiveness, manufacturing quality or consistency, and it issued more than 50 warning letters in September 2025 to companies compounding or manufacturing these substances over statements it deemed false or misleading.
Atlas makes no efficacy claims and no guarantees about any medication or supplement, and does not choose your sourcing. Those decisions belong to the separately licensed medical entity that delivers care. What Atlas licenses is the business system around it.
Question one: who may co-own the professional entity
Michigan's Limited Liability Company Act speaks to this directly. MCL 450.4904(2) provides that where a professional limited liability company renders a service included within the public health code, all members and managers must be "licensed or legally authorized in this state to render the same professional service." That is statutory text, not an answer for your structure.
This matters more than usual for a metabolic program, which frequently wants a physician, a nurse practitioner and a non-clinician operator inside one cap table. Ask your Michigan counsel whether that combination fits the same-profession rule and its enumerated exceptions for your entity type, and confirm with LARA's corporations bureau. If it does not, the clinical and business entities separate and connect by agreement.
When it does, the fee methodology becomes the exposed surface. A management fee shaped as a share of clinical revenue behaves exactly like a royalty, which is why FDD Item 6 and how a gross royalty compounds is the right primer before you agree to any percentage anywhere in your stack.
Question two: consent before a telehealth service
MCL 333.16284 provides, subject to a narrow correctional exception, that "a health professional shall not provide a telehealth service without directly or indirectly obtaining consent for treatment." Implementing board rules such as Mich. Admin. Code R. 338.2526 require proof of consent in the medical record. That is procedural rather than a standard-of-care statement, and it either lives in your intake workflow from day one or shows up as a documentation gap across every chart.
Which board rules govern your particular clinicians, and what your consent language must contain, is not settled by the statute alone. Ask your Michigan counsel, and confirm the current text against the relevant LARA board directly. Then make it a workflow requirement, not a training point, because compliance should be structural rather than remembered.
Ask Atlas to put this in writing: whether the Atlas telehealth stack ships with a configurable pre-treatment telehealth consent step for states like Michigan that require one
Question three: the Michigan controlled substance license
MCL 333.7303 requires a person who prescribes or dispenses a controlled substance in Michigan to obtain a license issued by the administrator, and LARA's Board of Pharmacy issues that individual license separately from the professional license. Federal DEA registration is separate again; ask counsel how both apply to each prescriber you credential.
On staffing, a Michigan health law firm summarises the advanced-practice rule this way: "an APRN can prescribe controlled substances in schedules 2 through 5 when delegated the authority by a physician." Ask your Michigan counsel whether that delegation fits your staffing model, and confirm it against the Michigan Board of Nursing before you hire. Federal registration is the fixed part at 888 dollars per three-year term under 21 CFR 1301.13.
GLP-1 receptor agonists are not controlled substances. The reason to settle this early is scope: a program that later adds a scheduled category needs the credential before it advertises the service, and the lead time is not zero.
Question four: physicians, osteopaths and one department for everything
Michigan regulates physicians through the Michigan Board of Medicine and osteopathic physicians through the Michigan Board of Osteopathic Medicine and Surgery, both administered by the Department of Licensing and Regulatory Affairs. LARA also houses the Corporations, Securities and Commercial Licensing Bureau, so entity formation and professional licensing sit under one department.
Ask counsel to lay out the sequence: entity formation, professional entity qualification, individual licensure verification, controlled substance credentials where applicable, then local registration in Detroit. The order is not interchangeable.
Which model you are building toward should be settled before that sequence starts, and the clinic model versus the digital model comparison is the honest version of that decision for a metro like Detroit where a physical location carries real weight with members.
Question five: Detroit's city income tax and local layer
Detroit levies a city income tax that includes a corporate income tax and employer withholding, and since January 2017 the Michigan Department of Treasury has administered Detroit corporate income tax return processing and collected employer withholding. If your build has employees at a Detroit address, withholding registration is a day-one payroll item.
Confirm current rates, registration requirements and any city business licensing for your specific address and activity with the City of Detroit and the Michigan Department of Treasury or your accountant. This page is a prompt list, not a tax opinion, and nothing here should be used to estimate what any business will owe or collect.
On the demand side, a metro build lives or dies on local acquisition rather than national brand, which is why local marketing for wellness is worth reading before the first dollar goes into media in Wayne, Oakland or Macomb County.
What an Atlas build hands a Detroit partner
The license covers the telehealth stack, the ordering system, member AI coaching, the brand kit and the operational playbooks, delivered as a single build rather than a subscription drip. Atlas provides no medical services and employs no clinicians, and takes no position on Michigan law.
Terms: one-time license fee, zero percent of partner revenue, no ongoing partner fees, no assigned exclusive geography. Franchises sell territory and enforce it; Atlas does not sell geography, so a Detroit market is a decision you make about where to operate. The fee is disclosed on the fit call rather than published, by design. The license fee is one-time. It carries 0% of revenue and no ongoing partner fees. The figure is not published anywhere, by design — it is disclosed in full on the fit call, where it can be put next to what it covers instead of floating on its own.
— only a named, consented Atlas partner, quoted verbatim with written permission on file. No composites, no invented names, no stock imagery. When your counsel has answered the ownership, consent and controlled substance questions, take the answers to the apply page.
What this page is not
This is general commentary published by Atlas Metabolic. Atlas is not a law firm and nothing here is legal, tax or medical advice. Where a statute or rule is quoted above it is quoted narrowly and linked so you can read it yourself; a quotation is not an opinion about your situation.
Regulation in this area changes and varies by structure. Two Detroit builds with different entity types or service lines can get different answers from the same statute, and statutes and board rules are amended.
Every question above belongs to your own healthcare counsel licensed in Michigan, and to the relevant Michigan board, before you commit money or sign anything. Atlas provides no medical services and employs no clinicians; clinical care is delivered by a separately licensed medical entity.
- Michigan Legislature, MCL 450.4904 — Where a professional limited liability company renders a professional service included within the public health code, all members and managers must be "licensed or legally authorized in this state to render the same professional service" (subsection 2), with enumerated exceptions for certain listed professions. (source) [VERIFIED]
- Michigan Legislature, MCL 333.16284 — "A health professional shall not provide a telehealth service without directly or indirectly obtaining consent for treatment," subject to a narrow exception for inmates in Department of Corrections facilities. (source) [VERIFIED]
- Michigan Administrative Code R. 338.2526 (via Cornell Legal Information Institute) — "A licensee shall obtain consent for treatment before providing a telehealth service under section 16284 of the code, MCL 333.16284," and shall keep proof of consent in the patient's medical record per MCL 333.16213. (source) [VERIFIED]
- Michigan Legislature, MCL 333.7303 — A person who manufactures, distributes, prescribes or dispenses a controlled substance in Michigan, or proposes to, must obtain a license issued by the administrator in accordance with the rules. (source) [VERIFIED]
- Michigan LARA Board of Pharmacy, Controlled Substance Individual Licensing Guide — LARA issues the individual controlled substance license; a prescriber at more than one location needs only one controlled substance license, and it expires on the same date as the professional license. (source) [VERIFIED]
- Chapman Law Group (Michigan health law firm client resource) — "As of April 9, 2017, an APRN can prescribe controlled substances in schedules 2 through 5 when delegated the authority by a physician," with both DEA registration numbers indicated on the prescription. (source) [VERIFIED]
- Michigan Department of Licensing and Regulatory Affairs — LARA administers Michigan's Board of Medicine and Board of Osteopathic Medicine and Surgery and health professional licensing generally. (source) [VERIFIED]
- Michigan LARA, Corporations, Securities and Commercial Licensing Bureau — Michigan business and professional entities are formed and filed through LARA's corporations bureau. (source) [VERIFIED]
- City of Detroit, Office of the Treasury — Detroit levies a city income tax, including a business/corporate income tax and employer withholding. (source) [VERIFIED]
- Michigan Department of Treasury, City of Detroit Employer Withholding Tax — Beginning January 2017 the Michigan Department of Treasury administers City of Detroit corporate, partnership and fiduciary income tax return processing and collects and enforces employer withholding. (source) [VERIFIED]
- IQVIA US blog, October 2025 — Compounded semaglutide and tirzepatide prescribing continued to rise after delisting; more than 80 percent of compounded prescriptions include supplemental ingredients; anti-obesity patients were approximately 83 percent of the compounded market during the shortage; roughly 2 percent of compounded patients switched to branded products monthly. (source) [VERIFIED]
- US FDA — A compounded product with the same active ingredient is not the drug FDA reviewed and approved; FDA does not evaluate specific compounded products for safety, effectiveness, manufacturing quality or consistency; FDA issued more than 50 warning letters in September 2025 to companies compounding or manufacturing semaglutide and tirzepatide. (source) [VERIFIED]
- US Code of Federal Regulations, 21 CFR 1301.13 — DEA practitioner registration is 888 dollars for a three-year registration period. (source) [VERIFIED]
- Atlas Metabolic (editorial inference, not a legal authority) — How the quoted Michigan statutes and rules apply to any specific multi-entity metabolic program structure, cap table, staffing model or consent workflow is not addressed by any source cited above; those applications are framed on this page as questions for the reader's own Michigan healthcare counsel and the relevant Michigan board. [INFERENCE]